Mohs surgery for squamous cell carcinoma: when it is the right choice

Squamous cell carcinoma is the second most common skin cancer, and its behavior is exactly what Mohs micrographic surgery is built to handle. Squamous cell carcinoma, or SCC, arises from the flat keratinocytes of the outer skin, and unlike most basal cell cancers it carries a real, if usually small, risk of spreading when it is neglected or aggressive. That combination of frequency and potential seriousness is why precise, complete removal matters so much. According to the American Academy of Dermatology, SCC is highly curable when it is caught and treated early, and the treatment chosen should reflect the tumor's individual risk.

Not every squamous cell cancer needs Mohs, but many higher-risk ones do. Guidelines reserve Mohs for tumors where its complete margin control counts most: SCCs on the face, ears, lips, and other high-risk locations, tumors that are large, poorly defined, or fast growing, and aggressive microscopic subtypes such as poorly differentiated tumors that tend to send roots well beyond what the eye can see. The published Appropriate Use Criteria map tumor type, size, and location to whether Mohs is the recommended approach, and a large share of concerning SCCs land squarely in that range. A small, low-risk SCC on the trunk or limb, by contrast, is often handled well by simpler standard excision.

The feature that makes Mohs so effective for SCC is the one that defines the technique. Because the surgeon removes the tumor a thin layer at a time and reads essentially the entire margin under the microscope before closing, Mohs follows the cancer wherever it actually reaches rather than guessing at a fixed border. Squamous cell cancers are notorious for extending in irregular, subclinical ways, so a standard excision with a preset margin can leave stealthy roots behind. Complete margin examination is designed to catch exactly those extensions in a single visit.

Cure rates for squamous cell carcinoma with Mohs are among the highest reported. For primary SCCs, Mohs achieves cure rates commonly cited around 97 percent, meaningfully higher than standard excision, and it remains the strongest option for tumors that have already come back. As with basal cell carcinoma, the figure reflects what complete margin control actually buys you: the near-certainty that no tumor remained at the edges on the day of surgery, plus the smallest wound the tumor allowed.

Perineural spread is a particular reason an SCC gets referred for Mohs. Some squamous cancers travel along the tiny nerves in the skin, a pattern called perineural invasion that a biopsy may flag. These tumors can extend surprisingly far from the visible lesion, and they are among the trickiest to clear with a blind margin. The layer-by-layer mapping of Mohs is well suited to chasing that kind of spread, which is one reason the technique is favored when the pathology report raises this concern.

Mohs clears the local tumor, but high-risk SCC sometimes needs more than surgery. Because a small fraction of squamous cell cancers can spread to nearby lymph nodes or beyond, a surgeon treating a high-risk SCC may recommend imaging, a lymph node evaluation, or coordination with an oncology team in addition to removal. The Mayo Clinic notes that most squamous cell carcinomas result from long-term sun exposure and are curable, while a minority behave more aggressively and warrant closer monitoring. Mohs handles the local disease with exceptional reliability; the broader workup addresses the separate question of whether the cancer has traveled.

Recovery and reconstruction follow the same day. Once the margins are confirmed clear, the surgeon usually repairs the wound in the same visit, choosing the reconstruction that best preserves the feature. Because Mohs removes only tissue that actually contains cancer, it tends to leave a smaller defect than a wide excision would, which is a real advantage for SCCs on the face, scalp, and hands where healthy skin is precious.

The takeaway for a patient told they have a squamous cell carcinoma is reassuring. This is a common, usually curable cancer, and for the higher-risk tumors, those in delicate locations, with aggressive features, with perineural invasion, or that have recurred, Mohs offers the most reliable clearance available. The step most associated with getting both the cure and the cosmetic result right is choosing an experienced, fellowship-trained Mohs surgeon and confirming with them that your particular SCC meets the criteria where Mohs shines. For more on how the technique compares across cancer types, see why Mohs is the gold standard for basal cell carcinoma.